GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (NSE:SOLARA) » Definitions » PE Ratio (TTM)

Solara Active Pharma Sciences (NSE:SOLARA) PE Ratio (TTM) : At Loss (As of Dec. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Solara Active Pharma Sciences PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-12), Solara Active Pharma Sciences's share price is ₹759.30. Solara Active Pharma Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-136.83. Therefore, Solara Active Pharma Sciences's PE Ratio (TTM) for today is At Loss.


The historical rank and industry rank for Solara Active Pharma Sciences's PE Ratio (TTM) or its related term are showing as below:

NSE:SOLARA' s PE Ratio (TTM) Range Over the Past 10 Years
Min: At Loss   Med: 20.18   Max: 85.46
Current: At Loss


During the past 8 years, the highest PE Ratio (TTM) of Solara Active Pharma Sciences was 85.46. The lowest was 0.00. And the median was 20.18.


NSE:SOLARA's PE Ratio (TTM) is ranked worse than
100% of 601 companies
in the Drug Manufacturers industry
Industry Median: 22.93 vs NSE:SOLARA: At Loss

Solara Active Pharma Sciences's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was ₹2.54. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-136.83.

As of today (2024-12-12), Solara Active Pharma Sciences's share price is ₹759.30. Solara Active Pharma Sciences's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-99.01. Therefore, Solara Active Pharma Sciences's PE Ratio without NRI for today is At Loss.

During the past 8 years, Solara Active Pharma Sciences's highest PE Ratio without NRI was 48.34. The lowest was 0.00. And the median was 21.25.

Solara Active Pharma Sciences's EPS without NRI for the three months ended in Sep. 2024 was ₹2.54. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-99.01.

During the past 8 years, Solara Active Pharma Sciences's highest 3-Year average EPS without NRI Growth Rate was 11.40% per year. The lowest was 11.40% per year. And the median was 11.40% per year.

Solara Active Pharma Sciences's EPS (Basic) for the three months ended in Sep. 2024 was ₹2.54. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-136.83.


Solara Active Pharma Sciences PE Ratio (TTM) Historical Data

The historical data trend for Solara Active Pharma Sciences's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences PE Ratio (TTM) Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PE Ratio (TTM)
Get a 7-Day Free Trial 10.35 21.61 At Loss At Loss At Loss

Solara Active Pharma Sciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only At Loss At Loss At Loss At Loss At Loss

Competitive Comparison of Solara Active Pharma Sciences's PE Ratio (TTM)

For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solara Active Pharma Sciences's PE Ratio (TTM) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where Solara Active Pharma Sciences's PE Ratio (TTM) falls into.



Solara Active Pharma Sciences PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Solara Active Pharma Sciences's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=759.30/-136.828
=At Loss

Solara Active Pharma Sciences's Share Price of today is ₹759.30.
Solara Active Pharma Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-136.83.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Solara Active Pharma Sciences  (NSE:SOLARA) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


Solara Active Pharma Sciences PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


Solara Active Pharma Sciences Business Description

Traded in Other Exchanges
Address
27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127
Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines